Heaton and Luder Receive National Pharmacy Association Recognition

Two faculty members from the University of Cincinnati James L. Winkle College of Pharmacy are among the American Pharmacists Association (APhA) 2016 Awards and Honors Program recipients. 

Chair and Associate Professor Pamela Heaton, PhD, and Assistant Professor Heidi Luder, PharmD, in the college’s division of pharmacy practice and administration, will be officially recognized at the APhA Annual Meeting and Exposition March 4–7, 2016 in Baltimore, Maryland.

In the category of American Pharmacists Association Academy of Pharmaceutical Research and Science (APhA-APRS) Awards: 

·         Heaton will receive the Wiederholt Prize. The award recognizes the best paper published in the Journal of the American Pharmacists Association (JAPhA), within the past two calendar years, describing original investigation in the areas of economic, social or administrative sciences. Heaton was selected in recognition of her paper, "U.S. emergency departments visits resulting from poor medication adherence: 2005–07,” published in the September/October 2013 issue of the JAPhA.

·         Luder will receive the Clinical Research Paper Award. The award promotes and encourages high quality clinical research or practice based research in the clinical sciences by recognizing an original research article in this area which has been published in the Journal of the American Pharmacists Association (JAPhA). Luder was selected in recognition of her paper, "TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate,” which was published in the May/June 2015 issue of the JAPhA.

Founded in 1852, APhA is the largest association of pharmacists in the United States, with more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists and pharmacy technicians as members.

The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy and honorees.

Tags

Related Stories

1

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.

2

Is uACR the key to cardiovascular and kidney disease prevention?

March 8, 2026

As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.

3

Driven by her own pain

March 8, 2026

Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.